e-learning
resources
Vienna 2009
Monday, 14.09.2009
Animal models of airways inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adrenomedullin – a protective factor in asthma?
S. Hagner, H. Garn, H. Renz (Marburg, Germany)
Source:
Annual Congress 2009 - Animal models of airways inflammation
Session:
Animal models of airways inflammation
Session type:
Thematic Poster Session
Number:
2096
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hagner, H. Garn, H. Renz (Marburg, Germany). Adrenomedullin – a protective factor in asthma?. Eur Respir J 2009; 34: Suppl. 53, 2096
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
Asthma in elderly – What is the difference?
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012
Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Tuberculosis – An important risk factor for lung cancer
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
LATE-BREAKING ABSTRACT: Bullying in children with asthma – What factors are associated with increased risk?
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
Differential involvement of IκB kinases α and β in asthma and COPD
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Treatment of sarcoidosis – pentoxifylline
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
The
in vitro
biology of PF-00610355 – a novel β
2
adrenoceptor agonist with a long duration of action
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
The
in-vitro
pharmacology of PF-3429281 – A novel inhaled dual antimuscarinic/β
2
adrenoceptor agonist
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
EGFR – a useful biomarker?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
α-b crystallin – a marker for inflammation in COPD patients
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Asthma medication and antibiotics – Cause or effect?
Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma
Year: 2010
BAMBI – A TGF-β pseudoreceptor with possible functional involvement in COPD and NTHI infection
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Oral glucocorticoid treatment of severe asthma – Current practice in the US
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
LATE-BREAKING ABSTRACT: The role of prostacyclin in endothelial – eosinophil interaction
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
The
in-vitro
pharmacology of PF-4522971 – A novel inhaled Muscarinic M
3
Antagonist
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
How should we investigate the child with difficult asthma – Is there any evidence?
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Evaluation of difficult asthma – a single centre experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Chronic non-asthmatic cough – Are we nearer to define the airway pathology?
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Eosinophil cationic protein in children with respiratory allergies – When is it useful?
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept